![Matthew Korenberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Korenberg
Direttore/Membro del Consiglio presso
PFENEX INC.
Patrimonio netto: 448 294 $ in data 31/07/2026
Profilo
Matthew Edward Korenberg was the founder of Neurocircuit Therapeutics, Inc., founded in 2013, where the title held was Chief Executive Officer & Director.
Current jobs include Director at Qualigen, Inc.; Director at The Pelican, Inc. since 2020; Director at Ligand UK Group Ltd. since 2018; Independent Director at Lifecore Biomedical, Inc. since 2024; and Chief Financial Officer, Secretary & Treasurer at Palvella Therapeutics, Inc. since 2024.
Former jobs include Director at Ligand UK Ltd.; Managing Director at Goldman Sachs & Co. LLC.
from 1999 to 2013; Independent Director at AIxCrypto Holdings, Inc. from 2020 to 2024; Director at Ligand UK Research Ltd.; and President & Chief Operating Officer at Ligand Pharmaceuticals, Inc. from 2022 to 2024.
Education includes undergraduate studies at the University of Michigan.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 04/06/2026 | 69.967 ( 0,19% ) | 309 254 $ | 31/07/2026 | |
0,01% | 12/06/2026 | 1.000 ( 0,01% ) | 139 040 $ | 31/07/2026 |
Posizioni attive di Matthew Korenberg
| Società | Posizione | Inizio |
|---|---|---|
| PFENEX INC. | Direttore/Membro del Consiglio | 01/10/2020 |
| LIFECORE BIOMEDICAL, INC. | Direttore/Membro del Consiglio | 01/08/2024 |
Ligand UK Group Ltd.
 Ligand UK Group Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Direttore/Membro del Consiglio | 12/10/2018 |
Qualigen, Inc.
 Qualigen, Inc. Medical SpecialtiesHealth Technology Develops and manufactures automated blood testing systems | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Matthew Korenberg
| Società | Posizione | Fine |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Presidente | 31/10/2024 |
| AIXCRYPTO HOLDINGS, INC. | Direttore/Membro del Consiglio | 03/10/2024 |
Ligand UK Research Ltd.
 Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direttore/Membro del Consiglio | 19/03/2024 |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/08/2013 |
| VERNALIS | Direttore/Membro del Consiglio | - |
Formazione di Matthew Korenberg
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
88
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Lifecore Biomedical, Inc.
 Lifecore Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Develops and sells sterile injectable pharmaceutical products | Health Technology |
Ligand UK Ltd.
 Ligand UK Ltd. BiotechnologyHealth Technology Engages in research and development & sells pharmaceutical products | Health Technology |
Qualigen, Inc.
Qualigen, Inc. Medical SpecialtiesHealth Technology Develops and manufactures automated blood testing systems | Health Technology |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Ligand UK Research Ltd.
Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pelican Inc
 Pelican Inc Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical therapeutics and vaccines | Health Technology |
Ligand UK Group Ltd.
Ligand UK Group Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Neurocircuit Therapeutics, Inc. | |
Qualigen Therapeutics, Inc.
 Qualigen Therapeutics, Inc. Packaged SoftwareTechnology Services Develops global ecosystem platform that integrates AI and blockchain systems to connect web apps | Technology Services |
